Intestinal epithelial dysplasia, also called tufting enteropathy or congenital tufting enteropathy, is a very rare inherited disease of the gut lining. In this condition, the cells on the inside surface of the small intestine do not join and mature normally, so the bowel cannot absorb water, salts, and nutrients well. Many babies develop severe watery diarrhea very early in life, often in the first days or weeks, and many need long-term nutrition and fluid support. Most reported cases are linked to EPCAM changes, while some syndromic cases are linked to SPINT2 changes. The main treatment is supportive care, because there is no proven drug that cures the epithelial defect itself at this time. [1][2][3][4][5]
This disease means the inner lining of the intestine is built in an abnormal way. Under the microscope, doctors can see small groups of surface cells that look crowded and piled up; this is called tufting. Because the lining is weak and disorganized, fluid moves into the intestine and stays in the stool instead of being absorbed back into the body. That is why diarrhea can be severe, long-lasting, and dangerous. The disease may also cause poor growth, dehydration, low body salts, malnutrition, and intestinal failure. In severe cases, life depends on a central line and parenteral nutrition. [1][2][4][6]
Intestinal epithelial dysplasia is a very rare inherited disease of the small intestine. Today, doctors usually call it congenital tufting enteropathy, or tufting enteropathy. In this disease, the lining cells of the intestine do not join and mature in the normal way. Because of that, the bowel cannot absorb water, salts, and nutrients well. Most babies become sick very early in life with severe watery diarrhea, dehydration, and poor weight gain. The disease is usually autosomal recessive, which means a child inherits a changed gene from both parents. The two best-known genes are EPCAM in the usual isolated form and SPINT2 in the syndromic form. [1] [2] [3]
Other names
Other names used for this disease are congenital tufting enteropathy, tufting enteropathy, IED, congenital enteropathy, and congenital familial intractable diarrhea with enterocyte assembly abnormalities. These names describe the same core problem: an abnormal intestinal surface lining with typical tiny “tufts” of crowded cells seen on biopsy. [1] [2]
Types
Type 1: Isolated or classic intestinal epithelial dysplasia. This is the more common form. It mainly causes severe chronic diarrhea and growth failure, and it is most often linked to biallelic EPCAM mutations. [1] [2]
Type 2: Syndromic intestinal epithelial dysplasia. This form includes the bowel disease plus problems outside the intestine, especially choanal atresia, anal atresia, and eye problems such as photophobia, corneal erosions, or superficial punctate keratitis. It is mainly linked to SPINT2 mutations. [1] [2] [3]
Causes
The main proven direct causes are mutations in EPCAM and SPINT2. The other items below are disease-causing mechanisms, inherited patterns, or strong biologic contributors that explain why the disease happens. [1] [2] [3]
1. Biallelic EPCAM mutation. This is the best-known direct cause of the usual form. When both copies of the EPCAM gene are faulty, intestinal lining cells lose normal structure and function. [1] [2]
2. Biallelic SPINT2 mutation. This is the main direct cause of the syndromic form, where bowel disease happens with other body abnormalities. [1] [2]
3. Autosomal recessive inheritance. The disease usually appears when a child receives one changed gene from each parent. That is why family history can matter even when the parents look healthy. [1] [2]
4. Consanguinity. Marriage between close relatives does not directly damage the intestine, but it raises the chance that both parents carry the same rare pathogenic variant. [1] [2]
5. Loss of normal EpCAM protein. EpCAM helps intestinal cells stay organized. When it is absent or very low, the epithelial layer becomes unstable. [1] [2]
6. Abnormal EpCAM localization. In some mutations, the protein may be made but is weak, misplaced, or unstable, so it still cannot support normal epithelial function. [1] [2]
7. Claudin-7 destabilization. EpCAM normally works with claudin-7, a tight-junction protein. When this partnership fails, the barrier leaks more easily. [1] [2]
8. Tight-junction defects. Tight junctions are the seals between cells. Damage to these seals can increase fluid loss into the bowel lumen and worsen diarrhea. [1] [2]
9. Defective cell-to-cell adhesion. The epithelial cells do not hold each other in a normal pattern, so the surface becomes irregular and fragile. [1] [2]
10. Enterocyte crowding and tuft formation. The classic “tufts” are not just a sign under the microscope; they reflect an underlying structural disease of the lining cells. [1] [2]
11. Villous atrophy. The finger-like villi become short or flat, reducing absorptive surface area and worsening malabsorption. [1] [2]
12. Crypt hyperplasia. The crypts become enlarged because the bowel tries to repair itself, but this repair is abnormal and not enough to restore function. [1] [2]
13. Basement membrane abnormalities. Some reports describe abnormal basement membrane material, including altered laminin or heparan sulfate proteoglycan patterns. [1] [2]
14. Desmosome abnormalities. Electron microscopy can show longer and more numerous desmosomes, supporting the idea that epithelial attachment is abnormal. [1] [2]
15. Defective epithelial differentiation. The lining cells do not mature normally, so the intestine cannot perform its usual digestive and absorptive work. [1] [2]
16. Increased intestinal permeability. A weakened barrier lets fluid and electrolytes move abnormally, which contributes to persistent diarrhea. [1] [2]
17. Matriptase–prostasin pathway dysregulation. In SPINT2-related disease, poor control of these enzymes can injure EpCAM-related epithelial stability. [1] [2]
18. Sodium transport dysregulation in syndromic disease. SPINT2-related disease overlaps with congenital sodium diarrhea biology, showing how ion transport problems may worsen bowel fluid loss. [1] [2]
19. Rare other unknown genes. Some patients with typical disease do not have EPCAM or SPINT2 mutations, so researchers think additional genes may exist. [1] [2]
20. Positive family history of early intractable diarrhea. This is not the molecular cause by itself, but it is an important inherited clue that supports an underlying monogenic enteropathy. [1] [2]
Symptoms
1. Severe watery diarrhea from the newborn period or early infancy. This is the most important symptom. The diarrhea is usually persistent and does not stop easily. [1] [2] [3]
2. Intractable diarrhea despite normal feeding changes. Many babies stay sick even after formula changes or bowel rest, which makes doctors suspect a congenital enteropathy. [1] [2]
3. Dehydration. Large fluid loss in stool can quickly dry the body and become dangerous in infants. [1] [2]
4. Electrolyte imbalance. Babies may lose sodium and other salts, causing weakness, poor feeding, or serious illness. [1] [2]
5. Failure to thrive. The child does not gain weight and grow normally because the bowel cannot absorb enough nutrition. [1] [2] [3]
6. Poor weight gain. This may be noticed before the final diagnosis and is often one of the first long-term clues. [1] [2]
7. Malnutrition. Ongoing loss of nutrients can lead to protein-energy malnutrition and weakness. [1] [2]
8. Need for parenteral nutrition. Many children cannot maintain growth by mouth alone and need intravenous nutrition for support. [1] [2] [3]
9. Abdominal distension or bloating. This is not always the main feature, but it can happen with severe malabsorption and bowel dysfunction. [1] [2]
10. Recurrent hospital admissions for fluid problems. Severe diarrhea often causes repeated acute illness, especially in early life. [1] [2]
11. Eye symptoms such as photophobia. Light sensitivity is especially reported in syndromic cases. [1] [2]
12. Corneal erosions or superficial punctate keratitis. These eye surface problems are important clues to the syndromic form. [1] [2]
13. Choanal atresia. Some syndromic patients are born with blockage at the back of the nose. [1] [2]
14. Anal atresia. Some children have associated anorectal malformation in the syndromic form. [1] [2]
15. Chronic intestinal failure. In severe cases the bowel cannot support normal life without long-term medical nutrition support. [1] [2] [3]
Diagnostic tests
Physical exam
1. Growth and weight assessment. Doctors measure weight, length, and head growth to look for failure to thrive. [1] [2]
2. Dehydration exam. Dry mouth, sunken eyes, poor skin turgor, and low urine output can show major fluid loss. [1] [2]
3. Nutrition assessment. The doctor looks for fat loss, muscle wasting, and signs of vitamin or protein deficiency. [1] [2]
4. Abdominal examination. The abdomen is checked for distension, bowel sounds, tenderness, and surgical clues. [1] [2]
5. Eye and malformation screening. The doctor looks for photophobia, corneal disease, anal atresia, or choanal atresia, which suggest syndromic disease. [1] [2]
Manual or bedside tests
6. Stool volume and stool pattern observation. Careful bedside recording helps show that diarrhea is high-volume and persistent. [1] [2]
7. Feeding response assessment. Doctors observe whether diarrhea changes with fasting or formula changes; persistent diarrhea raises suspicion for congenital enteropathy. [1] [2]
Lab and pathological tests
8. Serum electrolytes. Blood sodium, potassium, chloride, and bicarbonate help measure the severity of fluid and salt loss. [1] [2]
9. Kidney function tests. Urea and creatinine help show dehydration effects and guide urgent treatment. [1] [2]
10. Serum albumin and total protein. These help detect malnutrition and protein loss. [1] [2]
11. Complete blood count. This test checks for anemia, infection, and the general effect of chronic disease and malnutrition. [1] [2]
12. Stool electrolytes. Stool sodium and chloride can help in the early evaluation of congenital diarrheal disorders. [1] [2]
13. Stool pH and reducing substances. These are useful supportive tests when doctors are sorting out causes of infant diarrhea and malabsorption. [1] [2]
14. Stool fat testing. This helps identify malabsorption patterns and rule out other intestinal disorders. [1] [2]
15. Small-bowel endoscopy with biopsy. This is one of the key tests because the diagnosis usually depends on seeing the mucosa directly and taking tissue samples. [1] [2] [3]
16. Routine histopathology of biopsy tissue. Pathologists look for villous atrophy, crypt hyperplasia, and focal epithelial tufts, which are classic findings. [1] [2] [3]
17. EPCAM immunohistochemistry. Loss or marked reduction of EpCAM staining in intestinal biopsy is very helpful, especially when the routine biopsy changes are subtle. [1] [2] [3]
18. Electron microscopy. This can show ultrastructural changes such as abnormal desmosomes and helps separate this disease from some other congenital enteropathies. [1] [2] [3]
19. Molecular genetic testing for EPCAM and SPINT2. Genetic testing is now a major confirmatory test and may reduce the need for repeated invasive procedures. [1] [2] [3]
Electrodiagnostic or physiologic testing
20. Specialized intestinal transport studies. These are not the main everyday test, but in expert centers, physiologic evaluation of intestinal ion transport can support the broader workup of congenital diarrheal disorders, especially when diagnosis is difficult. [1] [2]
Non-pharmacological treatments
1. Parenteral nutrition (PN or TPN). This is the most important non-drug treatment for severe disease. PN gives protein, sugar, fat, vitamins, minerals, and fluid directly into a vein when the intestine cannot absorb enough nutrition. Its purpose is to keep the child alive, support growth, protect the brain, and prevent severe malnutrition. Its mechanism is simple: it bypasses the damaged intestine and delivers nutrition straight into the bloodstream. Many children with severe tufting enteropathy need long-term or home PN. PN can be life-saving, but it also needs careful monitoring because it can cause line infection, liver injury, and vein problems. [1][3][4][7]
2. Intravenous fluid replacement. Many patients lose large amounts of water and electrolytes in stool. IV fluid therapy replaces these losses quickly and helps correct dehydration, acidosis, and shock risk. The purpose is to keep blood pressure, kidney function, and circulation stable. The mechanism is direct replacement of fluid and salts such as sodium, potassium, chloride, and bicarbonate-related buffers. This is especially important during diarrhea flares, fever, vomiting, or line interruptions. In practice, IV fluids are often combined with lab monitoring so the fluid plan can be adjusted based on the child’s exact losses. [1][4][7]
3. Oral rehydration solution. Special oral rehydration drinks can help some patients absorb water better than plain water. Their purpose is hydration support, especially in patients who can safely drink by mouth. The mechanism is that glucose and sodium are absorbed together in the gut, and water follows that movement. Plain water, juice, and sugary drinks may worsen sodium loss in some intestinal-failure states, while proper oral rehydration solution is designed to improve net fluid uptake. This method does not cure the disease, but it can reduce dehydration risk and support daily care at home. [9][10]
4. Enteral feeding when tolerated. Even if full absorption is not possible, small amounts of milk or formula through the gut may still help the intestine adapt and maintain mucosal activity. The purpose is to stimulate the bowel, support feeding skills, and sometimes reduce full dependence on PN. The mechanism is trophic stimulation: nutrients inside the bowel can encourage digestive function, mucosal growth, and hormonal signaling. Not every patient tolerates this well, so feeding often starts slowly and is advanced carefully under specialist supervision. [3][4][7]
5. Breast milk or individualized formula strategy. Some infants do better with carefully selected feeds, including breast milk or specialized formulas, depending on tolerance. The purpose is to give the gentlest possible enteral nutrition and reduce secondary feeding stress. The mechanism is not disease reversal; it is better feeding compatibility, lower osmotic burden in some cases, and practical support for infant nutrition. However, changing formula alone usually does not stop the diarrhea of true tufting enteropathy, which helps distinguish it from more common feeding-related diarrhea conditions. [1][2][4]
6. Home parenteral nutrition program. When long-term PN is needed, home PN allows care outside the hospital. Its purpose is to improve quality of life, support family bonding, reduce hospital stay, and allow more normal development. The mechanism is organized outpatient delivery of nutrition through trained caregivers, pumps, sterile technique, and regular specialist follow-up. Published pediatric PN guidelines support home PN for children who are medically stable but remain dependent on long-term intravenous nutrition. [7][8]
7. Central venous catheter care education. Good line care is a core treatment, not just a small detail. The purpose is to prevent bloodstream infection, line blockage, thrombosis, and loss of venous access. The mechanism is strict sterile technique during dressing changes, tubing connection, flushing, and medication or PN administration. Because these children may need central access for years, preserving each line is very important. Poor line care can turn a manageable condition into a life-threatening emergency. [8][11]
8. Intestinal rehabilitation program. A specialized intestinal rehabilitation team usually includes gastroenterology, surgery, nutrition, nursing, pharmacy, social work, and sometimes transplant experts. The purpose is to reduce complications, improve growth, protect the liver, and decide when transplant referral is needed. The mechanism is coordinated long-term care rather than one isolated treatment. These programs have improved survival and reduced the need for transplant in many forms of chronic intestinal failure. [7][11][12]
9. Growth and nutrition monitoring. Frequent checks of weight, length or height, head growth in infants, and body composition are essential. The purpose is to detect underfeeding, micronutrient deficiency, and growth failure early. The mechanism is timely adjustment of calories, amino acids, lipids, electrolytes, and vitamins before severe decline develops. Because stool losses can be heavy and daily needs can change, careful growth tracking is one of the most useful tools in management. [3][7]
10. Micronutrient surveillance. Children with intestinal failure can develop low levels of zinc, selenium, iron, copper, vitamins, and essential fatty acids. The purpose is to prevent deficiency-related anemia, weak immunity, rash, poor wound healing, bone disease, and developmental problems. The mechanism is periodic blood testing followed by targeted replacement. Even when a child receives PN, levels can still drift over time, so routine surveillance matters. [7][11]
11. Stool and fluid loss measurement. Measuring diaper weight, ostomy output, stool amount, urine output, and daily intake can guide care. The purpose is to match fluid replacement to real losses and prevent dehydration. The mechanism is simple volume accounting that informs IV fluid, oral rehydration, and electrolyte plans. This becomes especially useful during illness, hot weather, travel, or feed changes. [7][9]
12. Liver protection strategy during PN. Long-term PN can injure the liver, so the care team often uses practical steps to reduce this risk. The purpose is to prevent cholestasis, fibrosis, and liver failure. The mechanism includes avoiding overfeeding, balancing lipid exposure, promoting enteral stimulation if possible, preventing sepsis, and monitoring liver tests closely. This is not one single therapy, but a bundled supportive strategy. [7][12]
13. Infection prevention bundle. Preventing catheter-related bloodstream infection is a major part of treatment. The purpose is to reduce sepsis, hospital admission, liver injury, thrombosis, and loss of line sites. The mechanism includes sterile line access, careful dressing care, hand hygiene, and specialized line protocols. Infection prevention has a strong effect on survival in children with intestinal failure. [8][11]
14. Genetic counseling. Because this is usually an inherited recessive disorder, families may benefit from counseling. The purpose is to explain the cause, recurrence risk, testing options, and implications for future pregnancies or siblings. The mechanism is education based on identified variants such as EPCAM or SPINT2. This does not treat diarrhea directly, but it is a clinically important part of comprehensive care. [2][5][6]
15. Developmental and feeding therapy. Long hospital stays and limited oral intake can delay oral skills and development. The purpose is to support swallowing, feeding tolerance, sensory comfort, and developmental milestones. The mechanism is guided therapy from feeding specialists, speech therapists, and occupational therapists. This can help the child remain engaged with oral experiences even when nutrition mainly comes from PN. [3][7]
16. Skin care around stooling or stomas. Constant watery stool can damage the skin badly. The purpose is to reduce pain, rash, infection risk, and breakdown. The mechanism is barrier creams, gentle cleansing, frequent diaper care, and ostomy-skin protection when needed. Although simple, skin care can greatly improve comfort and reduce secondary complications. [3][4]
17. Bone health monitoring. Long-term intestinal failure and chronic nutrition problems can weaken bones. The purpose is to prevent rickets, fractures, and poor mineralization. The mechanism is vitamin D, calcium, phosphorus, trace-element review, growth review, and imaging or density assessment when needed. Bone health is often overlooked, but it matters in children growing under chronic illness. [7][11]
18. Psychosocial support for family. This disease can put heavy emotional and financial stress on caregivers. The purpose is to improve treatment adherence, reduce burnout, and support safe home care. The mechanism is counseling, social work support, home nursing coordination, and caregiver training. Long-term rare disease care works better when families are supported, not left alone. [7][11]
19. Intestinal transplantation evaluation. In children with severe PN complications, transplant assessment may become necessary. The purpose is to consider a path away from lifelong PN when complications become dangerous. The mechanism is specialist evaluation of intestinal failure severity, vascular access status, infection burden, liver disease, and quality of life. Transplant is not first-line therapy, but it can be lifesaving in selected patients. [4][12][13]
20. Small bowel transplantation. This is the only treatment sometimes described as a potential “cure” for the intestinal failure caused by tufting enteropathy. The purpose is to replace the nonfunctioning bowel with donor intestine so the child may absorb nutrition enterally. The mechanism is organ replacement followed by immune suppression and close follow-up. It is major, high-risk surgery, but it may allow some patients to stop PN. [4][12][13]
Drug treatments
There is no FDA-approved medicine that specifically fixes intestinal epithelial dysplasia itself. The medicines below are used supportively for diarrhea, acid, bacterial overgrowth, nutrition-related complications, liver issues, or intestinal-failure management. FDA labels are for their approved uses, and use in tufting enteropathy may be individualized or off-label. [3][14]
1. Teduglutide (Gattex). Drug class: GLP-2 analog. FDA-approved use: short bowel syndrome patients dependent on parenteral support. Usual labeled dose: 0.05 mg/kg once daily by subcutaneous injection. Purpose in selected intestinal-failure patients is to improve intestinal absorption and lower PN needs. Mechanism: it promotes mucosal growth and functional adaptation in the remaining intestine. Main side effects can include abdominal pain, injection-site reactions, swelling, and GI complications; labeled monitoring is important. Evidence for tufting enteropathy is limited, so this is specialist-driven, not a routine cure. [15]
2. Loperamide. Drug class: peripheral anti-diarrheal opioid-receptor agonist. Purpose is to slow gut movement and reduce stool volume in some patients. Mechanism: it decreases intestinal motility and can increase fluid absorption time. FDA labeling supports symptomatic diarrhea control, but dosing must be chosen carefully in children, and overdose can cause serious heart rhythm problems. It does not correct the epithelial defect, and benefit in severe congenital diarrhea may be modest. [16]
3. Octreotide. Drug class: somatostatin analog. Purpose is to reduce intestinal secretions in selected high-output states. Mechanism: it suppresses release of several gastrointestinal hormones and can lower fluid secretion. It is not a standard cure for tufting enteropathy, but it may be considered in special cases with very high losses. Side effects may include gallstones, glucose changes, abdominal symptoms, and slowed growth concerns in children. [17]
4. Omeprazole. Drug class: proton pump inhibitor. Purpose is to reduce stomach acid when reflux, acid injury, or secondary feeding intolerance is present. Mechanism: it blocks acid secretion from gastric proton pumps. It does not treat the genetic cause, but less acid may help upper-GI symptoms and reduce acid-related irritation. Side effects can include headache, diarrhea, and with longer use certain nutrient risks or infection concerns. [18]
5. Ursodiol. Drug class: bile acid agent. Purpose is treatment support for cholestasis or bile-flow problems that may appear during long-term PN. Mechanism: it helps improve bile flow and may reduce bile toxicity. It is used for liver-related complications rather than for the diarrhea itself. Side effects can include loose stool or abdominal discomfort. Liver protection remains mainly supportive and depends strongly on overall PN management and infection prevention. [7][12]
6. Metronidazole. Drug class: nitroimidazole antibiotic. Purpose is treatment of suspected small intestinal bacterial overgrowth or anaerobic infection when clinically indicated. Mechanism: it damages microbial DNA in susceptible organisms. It is not routinely given to all patients, but repeated antibiotic courses may be used in selected intestinal-failure patients with overgrowth-related bloating, worsening diarrhea, or malabsorption. Long use can cause neuropathy or nausea. [11][12]
7. Rifaximin. Drug class: gut-selective antibiotic. Purpose is also small intestinal bacterial overgrowth management in selected cases. Mechanism: it acts inside the intestinal lumen with low systemic absorption. This may make it useful when clinicians want an intestinal-targeted option. Side effects are often mild, but the decision depends on symptoms, stool pattern, and specialist judgment. [11][12]
8. Vancomycin oral. Drug class: glycopeptide antibiotic. Purpose is treatment of confirmed or strongly suspected C. difficile infection, not routine congenital diarrhea. Mechanism: it blocks bacterial cell wall synthesis inside the gut lumen. Severe chronic diarrhea patients can still develop secondary infections, and those episodes must be treated separately from the underlying disease. [11]
9. Ceftriaxone or other IV antibiotics. Drug class: cephalosporin antibiotic. Purpose is treatment of catheter-related bloodstream infection or sepsis when suspected. Mechanism: it kills susceptible bacteria systemically. In intestinal-failure patients, prompt treatment of line sepsis is critical because infection can threaten the line, liver, and life. Final antibiotic choice depends on cultures and local resistance patterns. [8][11]
10. Micafungin or fluconazole. Drug class: antifungal. Purpose is treatment of fungal line infection or invasive candidiasis when present. Mechanism: these drugs damage fungal cell membrane or cell wall pathways. Children with central lines and prolonged antibiotic exposure may need antifungal treatment in selected situations. [8][11]
11. Heparin flush. Drug class: anticoagulant. Purpose is to maintain catheter patency in some line-care protocols. Mechanism: it reduces clot formation inside the line lumen. It does not treat the bowel disease but helps preserve vascular access, which is essential for PN delivery. Protocols vary by center. [8]
12. Taurolidine catheter lock. Drug class: antimicrobial lock solution. Purpose is prevention of catheter-related bloodstream infection in selected long-term PN patients. Mechanism: it acts locally inside the catheter lumen to reduce microbial colonization. This is a supportive adjunct used by some centers as part of line-preservation strategy. [8]
13. Ethanol lock. Drug class: antiseptic lock solution. Purpose is another line infection prevention strategy in some programs. Mechanism: it decreases microbial growth inside the catheter lumen. It must be used according to specialist protocol because exposure time and line type matter. [8]
14. Zinc supplementation as medical therapy. Purpose is correction of zinc deficiency from chronic diarrhea. Mechanism: zinc supports epithelial repair, immune function, and enzyme activity. It may help deficiency-related poor growth and skin problems, but it is not a cure for tufting enteropathy. Dose depends on labs and age. [7][11]
15. Iron therapy. Purpose is treatment of iron deficiency anemia when present. Mechanism: it restores iron needed for hemoglobin formation. Chronic illness, poor intake, or blood loss can contribute to deficiency. Oral or IV route depends on tolerance and absorption. [7][11]
16. Vitamin D therapy. Purpose is prevention or treatment of deficiency and bone disease. Mechanism: it improves calcium and phosphorus handling and supports mineralization. Long-term malabsorption or complex nutrition support can increase deficiency risk. [7][11]
17. Vitamin B12 therapy. Purpose is correction of deficiency, especially in patients with ileal disease, resection, or long-term nutrition problems. Mechanism: it supports DNA synthesis and neurologic function. It helps deficiency-related complications rather than the primary epithelial defect. [7][11]
18. Folate therapy. Purpose is treatment of folate deficiency and support of red blood cell production. Mechanism: it is essential for cell division and DNA synthesis. It is used when testing or nutrition review suggests deficiency. [7][11]
19. Trace element replacement mixtures. These may include selenium, copper, manganese adjustments, and others as part of PN prescriptions. Purpose is deficiency prevention and safe long-term nutrition. Mechanism: trace elements serve as cofactors for enzyme systems, immunity, antioxidant defense, and tissue repair. [7]
20. Lipid-emulsion modification in PN. Although not a single classic “drug pill,” lipid emulsion choice is a real treatment decision in PN care. Purpose is to maintain calories while reducing PN-associated liver injury risk. Mechanism depends on fatty-acid composition and overall PN strategy. In intestinal-failure care, this is an important medical treatment tool. [7][12]
Dietary molecular supplements
Because absorption is often poor, these supplements are usually given only after specialist review. They help deficiency states or nutrition support, not the genetic root problem. [7][11]
1. Zinc. Usual dose depends on age, labs, and stool losses. Function: supports immunity, skin healing, enzyme activity, and growth. Mechanism: zinc is required for many cellular repair pathways and may be lost heavily in diarrhea. [7][11]
2. Vitamin D. Dose depends on blood level and age. Function: bone strength and calcium balance. Mechanism: improves calcium absorption and skeletal mineralization. [7][11]
3. Calcium. Dose is individualized. Function: bones, nerves, and muscles. Mechanism: replaces inadequate intake or low stores and works with vitamin D for bone support. [7][11]
4. Magnesium. Dose depends on serum level and stool loss. Function: nerve and muscle function. Mechanism: replaces losses that occur with chronic diarrhea and helps many enzyme reactions. [7][11]
5. Potassium. Dose is individualized by labs. Function: heart, muscle, and cellular function. Mechanism: corrects potassium loss from diarrhea or high-output stool. [7][11]
6. Sodium. Often very important in chronic diarrheal disease. Function: fluid balance and blood pressure support. Mechanism: replaces ongoing sodium loss and helps hydration. [9][10]
7. Iron. Dose depends on anemia severity and tolerance. Function: hemoglobin and oxygen transport. Mechanism: restores iron stores when deficiency is documented. [7][11]
8. Vitamin B12. Often given orally or by injection depending on absorption. Function: nerve health and blood formation. Mechanism: corrects deficiency caused by poor intake or absorption problems. [7][11]
9. Folate. Function: blood cell production and DNA synthesis. Mechanism: supports rapid cell turnover tissues and corrects deficiency states. [7][11]
10. Selenium. Function: antioxidant defense and thyroid-related enzyme systems. Mechanism: replaces deficiency that can develop during long-term nutrition problems or incomplete intake. [7][11]
Drugs sometimes discussed for immunity, regenerative support, or transplant care
There are no proven immune-booster or stem-cell drugs that cure intestinal epithelial dysplasia. The safest evidence-based approach is to say that these medicines are used only in very specific settings. [3][4][12]
1. Teduglutide is the main regenerative-style medicine sometimes discussed because it can improve intestinal adaptation in some intestinal-failure patients, although evidence in tufting enteropathy is limited. [15]
2. Growth hormone has been reported in isolated cases for growth support, but this is not standard disease therapy and evidence is very limited. [19]
3. Tacrolimus may be used after intestinal transplantation as an anti-rejection drug. Its purpose is graft protection, not pre-transplant cure. [12][13]
4. Mycophenolate may also be used in transplant immunosuppression plans. It reduces immune attack on the donor bowel after transplant. [12][13]
5. Corticosteroids can be part of transplant induction or rejection treatment, but they do not correct the congenital epithelial defect itself. [12][13]
6. Basiliximab or similar induction agents may be used in transplant programs to lower rejection risk in selected patients. These belong to transplant medicine, not routine early disease care. [12][13]
Surgeries or procedures
1. Central venous catheter placement. This is done to deliver PN and IV fluids safely over time. It is necessary when the bowel cannot support normal nutrition. [8]
2. Tunneled line replacement or repair. This may be needed if the line becomes infected, blocked, damaged, or unsafe. The purpose is to preserve long-term venous access. [8]
3. Feeding tube placement. Some children may need a gastrostomy or related feeding access to support careful enteral feeding and medication delivery. [3][7]
4. Ostomy-related procedures when needed. These are not routine for the disease itself, but may be required for associated bowel problems or surgical complications in selected patients. [3][4]
5. Small bowel or intestinal transplantation. This major surgery is considered when PN complications become severe, such as liver disease, repeated sepsis, or loss of vascular access. [4][12][13]
Prevention points
This disease usually cannot be prevented because it is genetic, but many complications can be prevented. Prevent central line infection with strict sterile care. Prevent severe dehydration by using the prescribed fluid plan. Prevent electrolyte imbalance with regular lab checks. Prevent malnutrition through close growth monitoring. Prevent liver injury by careful PN management and infection control. Prevent deficiency states by scheduled micronutrient testing. Prevent skin damage with stool-area protection. Prevent bone weakness with vitamin and mineral follow-up. Prevent delayed referral by early intestinal rehabilitation involvement. Prevent future diagnostic delay in families through genetic counseling. [2][7][8][11][12]
When to see doctors urgently
Get urgent medical care for reduced urine, marked weakness, sunken eyes, fast breathing, fever, shaking chills, blood in stool, severe vomiting, worsening abdominal swelling, line redness, pus, line pain, or confusion. These may mean dehydration, sepsis, bowel complication, or dangerous electrolyte imbalance. Also seek specialist review for poor growth, recurrent admissions, worsening liver tests, persistent diaper rash, feeding refusal, or frequent line problems. [4][7][8][11]
What to eat and what to avoid
Use the feeding plan given by the child’s gastroenterology team, because tolerance varies a lot. In general, use prescribed oral rehydration solution rather than random drinks. Use breast milk or specialist formula if advised. Give feeds slowly and exactly as instructed. Avoid very sugary drinks because they can worsen stool losses. Avoid changing formula repeatedly without specialist advice. Avoid unplanned herbal products or “immune boosters.” Avoid unsafe water or foods that raise infection risk in fragile children. Use supplements only after lab review. Continue any allowed oral feeding practice so feeding skills are not lost. [3][9][10][11]
FAQs
What is another name for intestinal epithelial dysplasia? It is commonly called tufting enteropathy or congenital tufting enteropathy. [1][4]
Is it genetic? Yes. Many cases are linked to EPCAM, and some syndromic cases involve SPINT2. [2][5][6]
Does formula change cure it? Usually no. The diarrhea generally continues despite usual feeding changes because the lining defect is structural and genetic. [1][4]
Is there a medicine that cures it? No proven drug cures the disease itself yet. Treatment is mainly supportive. [3][4]
Why is diarrhea so severe? Because the bowel lining cannot absorb fluid and nutrients normally. [1][2]
Can a child grow normally? Growth can improve with expert nutrition support, but close monitoring is necessary. [3][7]
Why is PN so important? PN bypasses the damaged intestine and can provide life-saving calories, protein, and fluids. [3][7]
Is home care possible? Yes, many stable children can receive home PN with careful training and follow-up. [7]
What is the biggest daily danger? Dehydration and line infection are two major dangers. [8][11]
Can plain water be enough? Not always. Some patients need specially balanced oral rehydration solution instead of plain water alone. [9][10]
Does every child need transplant? No. Many are managed medically, but some need transplant if PN complications become severe. [12][13]
When is transplant considered? Common reasons include severe liver disease, recurrent sepsis, or loss of venous access. [12][13]
Can antibiotics cure the disease? No. Antibiotics treat secondary infection or bacterial overgrowth, not the congenital epithelial problem. [11][12]
Why are vitamin and mineral tests repeated? Chronic diarrhea and long-term nutrition support can still lead to deficiency or imbalance. [7][11]
What specialists are needed? Usually pediatric gastroenterology, nutrition, intestinal rehabilitation, surgery, genetics, and line-care nursing teams. [4][7][8]
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: March 31, 2025.
